Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
14.47
+0.39 (2.77%)
Jun 24, 2026, 3:35 PM EDT - Market open
Xencor Employees
Xencor had 260 employees as of December 31, 2025. The number of employees increased by 10 or 4.00% compared to the previous year.
Employees
260
Change (1Y)
10
Growth (1Y)
4.00%
Revenue / Employee
$374,462
Profits / Employee
-$663,158
Market Cap
1.07B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 260 | 10 | 4.00% | 260 | 0 |
| Dec 31, 2024 | 250 | -30 | -10.71% | 250 | 0 |
| Dec 31, 2023 | 280 | -1 | -0.36% | 280 | 0 |
| Dec 31, 2022 | 281 | 27 | 10.63% | 281 | 0 |
| Dec 31, 2021 | 254 | 52 | 25.74% | 254 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MeiraGTx Holdings | 409 |
| Wave Life Sciences | 317 |
| DBV Technologies | 161 |
| ARS Pharmaceuticals | 159 |
| Sana Biotechnology | 142 |
| Absci | 140 |
| Cullinan Therapeutics | 109 |
XNCR News
- 6 weeks ago - Xencor Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Xencor Slides: Corporate presentation - Filings
- 6 weeks ago - Xencor price target raised to $14 from $13 at JPMorgan - TheFly
- 6 weeks ago - Xencor reports Q1 EPS ($1.71), consensus (75c) - TheFly
- 6 weeks ago - Xencor Reports First Quarter 2026 Financial Results - Business Wire
- 6 weeks ago - Xencor Earnings release: Q1 2026 - Filings
- 6 weeks ago - Xencor Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Xencor Transcript: Digestive Disease Week Conference - Transcripts